{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:06:43Z","timestamp":1764936403455},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00277-005-0075-z","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T09:37:19Z","timestamp":1138700239000},"page":"315-319","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload"],"prefix":"10.1007","volume":"85","author":[{"given":"S.","family":"Daar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Pathare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,1]]},"reference":[{"key":"75_CR1","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171\u20132179","journal-title":"Eur Heart J"},{"key":"75_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jmri.10332","volume":"18","author":"M Westwood","year":"2003","unstructured":"Westwood M, Anderson L, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 18:33\u201339","journal-title":"J Magn Reson Imaging"},{"key":"75_CR3","doi-asserted-by":"crossref","unstructured":"Ehlers KH, Giardina PJ, Lesser ML, Engle MA, and Hilgartner MW (1991) Prolonged survival in patients with beta-thalassemia major treated with deferioxamine. J Pediatr 540\u2013545","DOI":"10.1016\/S0022-3476(05)83374-8"},{"key":"75_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1365-2141.2001.03195.x","volume":"115","author":"JB Porter","year":"2001","unstructured":"Porter JB (2001) Practical Management of iron chelation. Br J Haematol 115:239\u2013252","journal-title":"Br J Haematol"},{"key":"75_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.04240.x","volume":"121","author":"FH Mourad","year":"2003","unstructured":"Mourad FH, Hoffbrand AV, Sheikh-Taha M, Kousa S (2003) Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassemia patients. Br J Hematol 121:187\u2013189","journal-title":"Br J Hematol"},{"issue":"9","key":"75_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJM199409013310902","volume":"331","author":"GM Brittenham","year":"1994","unstructured":"Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW (1994) Efficacy of deferioxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331(9):567\u2013573","journal-title":"N Engl J Med"},{"issue":"4","key":"75_CR7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","volume":"95","author":"SC Davis","year":"2000","unstructured":"Davis SC, Porter JB (2000) Long term outcome of continuous 24-hour deferioxamine infusion via indwelling intravenous catheters in high-risk beta thalassemia. Blood 95(4):1229\u20131236","journal-title":"Blood"},{"issue":"1","key":"75_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood.V91.1.295","volume":"91","author":"VA Hoffbrand","year":"1998","unstructured":"Hoffbrand VA, Wonke B (1998) Long-term deferiprone in 51 transfusion-dependant iron overloaded patients. Blood 91(1):295\u2013300","journal-title":"Blood"},{"key":"75_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","volume":"360","author":"LJ Anderson","year":"2002","unstructured":"Anderson LJ, Wonke B, Prescot E, Holden S, Walker MJ, Pennell J (2002) Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta thalassemia. Lancet 360:516\u2013520","journal-title":"Lancet"},{"issue":"Suppl 1","key":"75_CR10","first-page":"16b","volume":"92","author":"RW Grady","year":"1998","unstructured":"Grady RW, Berdoukas VA, Giardina PJ (1998) Iron chelators: combined therapy could be a better approach. Blood 92 (Suppl 1):16b","journal-title":"Blood"},{"key":"75_CR11","volume-title":"The thalassemia syndromes","author":"DJ Weatherall","year":"1981","unstructured":"Weatherall DJ, Clegg JB (1981) The thalassemia syndromes, 3rd edn. Blackwell, Oxford, U.K.","edition":"3"},{"key":"75_CR12","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica (10):1187\u20131193 (Oct 89)"},{"key":"75_CR13","first-page":"90","volume":"12","author":"P Pootrakul","year":"1981","unstructured":"Pootrakul P, Vongsmasa V, Laongpanich P, Wasi P (1981) Serum ferritin levels in thalassemia and the effect of splenectomy. Acta Haematol 12:90\u201393","journal-title":"Acta Haematol"},{"issue":"2","key":"75_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0168-8278(96)80070-5","volume":"25","author":"JP Villeneuve","year":"1996","unstructured":"Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25(2):172\u2013177","journal-title":"J Hepatol"},{"key":"75_CR15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2141.1995.tb08412.x","volume":"89","author":"E Anguelucci","year":"1995","unstructured":"Anguelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M (1995) Needle liver biopsy in thalassemia: analysis of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757\u2013761","journal-title":"Br J Haematol"},{"key":"75_CR16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2002-01-0306","volume":"100","author":"IR Wanless","year":"2002","unstructured":"Wanless IR, Sweeney G, Dhillon AP, Guido M, Piga A, Galanello R, Gamberini RM, Sahwartz E, Cohen AR (2002) Lack of progressive hepatic fibrosis during long-term therapy with Deferiprone in subjects with transfusion-dependent beta-thalassaemia. Blood 100:1566\u20131569","journal-title":"Blood"},{"key":"75_CR17","first-page":"101","volume":"309","author":"GM Brittenham","year":"1989","unstructured":"Brittenham GM, Allen CJ, Farrell DE, Harris JW (1989) Hepatic iron stores in thalassemia: non-invasive magnetic measurements. Prog Clin Biol Res 309:101\u2013106","journal-title":"Prog Clin Biol Res"},{"key":"75_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","volume":"103","author":"B Wonke","year":"1998","unstructured":"Wonke B, Wright S, Hoffbrand AV (1998) Combined therapy with deferiprone and desferrioxamine. Br J Haematol 103:361\u2013364","journal-title":"Br J Haematol"},{"key":"75_CR19","first-page":"493","volume":"55","author":"K Balveer","year":"2000","unstructured":"Balveer K, Pyar K, Wonke B (2000) Combined oral and parenteral iron chelation in beta thalassemia major. Med J Malays 55:493\u2013497","journal-title":"Med J Malays"},{"key":"75_CR20","first-page":"1309","volume":"90","author":"R Origa","year":"2005","unstructured":"Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessi C., Leoni G, Muroni Pier P, Galanello R (2005) Combined therapy with defeprone and desferrioxamine in thalassemia major. Haematologia 90:1309\u20131314","journal-title":"Haematologia"},{"key":"75_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000040962","volume":"102","author":"Y Aydinok","year":"1999","unstructured":"Aydinok Y, Nisli G, Kavakli K, Coker C, Kantar M, Cetingul N (1999) Sequential use of deferiprone and desferrioxamine in primary school children with thalassaemia major in Turkey. Acta Haematol 102:17\u201321","journal-title":"Acta Haematol"},{"key":"75_CR22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00277-005-1083-8","volume":"84","author":"M Franchini","year":"2005","unstructured":"Franchini M (2005) Recent acquisitions in the management of iron overload. Ann Hematol 84:640\u2013645","journal-title":"Ann Hematol"},{"key":"75_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0609.2004.00377.x","volume":"74","author":"R Naithani","year":"2005","unstructured":"Naithani R, Chandra J, Sharma S (2005) Safety of oral iron chelator deferiprone in young thalassemics. Eur J Haematol 74:217\u2013220","journal-title":"Eur J Haematol"},{"key":"75_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","volume":"102","author":"AV Hoffbrand","year":"2003","unstructured":"Hoffbrand AV, Cohen A, Hershko C (2003) Role of deferiprone in chelation therapy for transfusional iron overload. Blood 102:17\u201324","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-005-0075-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0075-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T03:51:54Z","timestamp":1652500314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-005-0075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-0075-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]},"assertion":[{"value":"25 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}